Medulloblastoma in a child with down syndrome: Long-term remission with multimodality treatment

Pediatric Blood and Cancer

Volumn 53, Issue 6, 2009, Pages 1150-1151

  Benesch, Martin ^a   Moser, Andrea ^a   Sovinz, Petra ^a   Lackner, Herwig ^a   Schwinger, Wolfgang ^a   Eder, Hans ^a   Urban, Christian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Down syndrome; Medulloblastoma; Metastases; Multimodality treatment

Indexed keywords

AMINOTRANSFERASE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FOLINIC ACID; LOMUSTINE; METHOTREXATE; VINCRISTINE;

ARTICLE; ATAXIA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CHILD; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DOWN SYNDROME; DRUG DOSE INCREASE; EPENDYMOMA; FATIGUE; GAIT DISORDER; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYDROCEPHALUS; LONG TERM CARE; MAINTENANCE THERAPY; MALE; MEDULLOBLASTOMA; MULTIMODALITY CANCER THERAPY; NEUROECTODERM TUMOR; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PAPILLEDEMA; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; SUBDURAL HEMATOMA; THROMBOCYTOPENIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DOWN SYNDROME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; REMISSION INDUCTION;

EID: 71049173333     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22109     Document Type: Article

References (10)

1. Alston RD, Newton R, Kelsey A, et al. Childhood medulloblastoma in northwest England 1954 to 1997: Incidence and survival. Dev Med Child Neurol 2003;45:308-314.
2. Johannesen TB, Angell-Andersen E, Tretli S, et al. Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999. Neuroepidemiology 2004;23:101-109.
3. Peris-Bonet R, Martínez-García C, Lacour B, et al. Childhood central nervous system tumours-Incidence and survival in Europe (1978-1997): Report from Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2064-2080.
4. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978-986. (Pubitemid 40349500)
5. von Hoff K, Hinkes B, Gerber NU, et al. Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer 2009;45:1209-1217.
6. Evans DG, Farndon PA, Burnell LD, et al. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 1991;64:959-961.
7. Raffel C. Medulloblastoma: Molecular genetics and animal models. Neoplasia 2004;6:310-322. (Pubitemid 38924846)
8. Satgé D, Rickert CH. A medical enigma: Persons with Down syndrome do not develop medulloblastoma. Neuroepidemiology 2009;32:164.
9. Rabin KR, Whitlock JA. Malignancy in children with trisomy 21. Oncologist 2009;14:164-173.
10. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000;355:165-169. (Pubitemid 30068214)